Pro-inflammatory Mediator Crosstalk Induces COX-2 in Myofibroblasts via PKC/PKD
Pro-inflammatory Mediator Crosstalk Induces COX-2 in Myofibroblasts via PKC/PKD
批准号:
8844124
负责人:
James Yoo
金额:
$7.63万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-05-01 至 2015-06-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
Following the completion of my surgical training in General and Colorectal Surgery, I sought an academic position where I would have the best opportunity to achieve my long-term career goals of becoming an independently funded investigator, as well as an outstanding clinician and teacher. My life-long mentor, Dr. Jeffrey Matthews, guided my decisions in terms of choosing an academic environment where these goals would be strongly supported. I met with Dr. Enrique Rozengurt during the recruitment process, and his willingness to serve as my research mentor was a major factor in my decision to join the UCLA Department of Surgery in 2006. With the full support of my department, I have been working with Dr. Rozengurt since my arrival at UCLA. Under his guidance, I have laid the groundwork of a research proposal (this grant) that will serve as the foundation of an independent research program. With the additional guidance and expertise of Dr. Charalabos Pothoulakis, and the full support of my Department of Surgery under the leadership of Dr. Ronald Busuttil, I feel well positioned to succeed in my pursuit of a successful research career. Dr. Rozengurt, Dr. Pothoulakis, and Dr. Busuttil comprise my Advisory Committee, and with their help I have designed a Career Development Plan consisting of graduate level courses, weekly research seminars/lectures, formal laboratory meetings, and participation in national research conferences. My short-term goals are to gain expertise in areas of signal transduction and murine models of inflammation and colitis-associated cancer as I develop my own distinct focus of research.
The association between chronic ulcerative colitis and the development of colorectal cancer is a well- established but incompletely understood phenomenon. Though the fundamental mechanism is not known, there has been a growing awareness of the contribution of the underlying intestinal stroma on inflammation-associated cancer. Colonic myofibroblasts are a subpopulation of cells located within the stroma of the GI tract that have been linked to both inflammation and tumorigenesis, and are a major source of cyclo-oxygenase 2 (COX-2), a critical enzyme also involved in these processes. However, the cell signaling pathways regulating COX-2 expression in myofibroblasts have not been well studied. Protein kinase D (PKD), the founding member of a new family of protein kinases that includes PKD2 and PKD3, has been implicated in important cellular functions but the expression, regulation and function of PKD in myofibroblasts, both in response to pro-inflammatory mediators and/or in the production of local regulators, has not been investigated. The central hypothesis of this proposal is that pro-inflammatory mediators activate a novel PKD phosphorylation cascade that plays a critical role in signal transduction pathways regulating colonic myofibroblast function. Using the human colonic myofibroblast cell line 18Co, our Preliminary Data demonstrate a synergistic upregulation of COX-2 protein expression following treatment with the inflammatory mediators TNF-( (TNF) and bradykinin (BK). This effect appears to be mediated by unique cross talk interactions between the distinct signaling pathways downstream of TNF and BK, leading to amplified PKD activation in direct association with a dramatic increase in COX-2 expression. The Specific Aims of this proposal are to 1) fully characterize the synergistic expression of COX-2 in response to pro-inflammatory mediators in colonic myofibroblasts, 2) identify mechanisms of signaling cross talk between pro-inflammatory mediators responsible for the synergy, 3) define the role of PKC/PKD signaling in the expression of COX-2 in myofibroblasts, and 4) substantiate the physiologic significance of these findings using a mouse model of colitis-associated cancer. Experimental results will also be confirmed using myofibroblast cells extracted from human colonic tissue taken at the time of surgery. Potential cross talk between TNF and BK in the synergistic enhancement of COX-2 expression in colonic myofibroblasts, mediated through PKD, may play an important role in colitis-associated cancer. PKD signaling may regulate key biological functions of myofibroblasts in the setting of inflammation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Novel In Vivo Mouse Model to Study Myofibroblast-Epithelial Cell Interactions
-
批准号:9262923
-
项目类别:
-
资助金额:$8.25万
-
财政年份:2016
-
负责人:James Yoo
-
依托单位:
Pro-inflammatory Mediator Crosstalk Induces COX-2 in Myofibroblasts via PKC/PKD
-
批准号:8927614
-
项目类别:
-
资助金额:$15.34万
-
财政年份:2014
-
负责人:James Yoo
-
依托单位:
Pro-inflammatory Mediator Crosstalk Induces COX-2 in Myofibroblasts via PKC/PKD
-
批准号:8468169
-
项目类别:
-
资助金额:$7.52万
-
财政年份:2010
-
负责人:James Yoo
-
依托单位:
Pro-inflammatory Mediator Crosstalk Induces COX-2 in Myofibroblasts via PKC/PKD
-
批准号:8317714
-
项目类别:
-
资助金额:$15.14万
-
财政年份:2010
-
负责人:James Yoo
-
依托单位:
Pro-inflammatory Mediator Crosstalk Induces COX-2 in Myofibroblasts via PKC/PKD
-
批准号:7989309
-
项目类别:
-
资助金额:$15.14万
-
财政年份:2010
-
负责人:James Yoo
-
依托单位:
Pro-inflammatory Mediator Crosstalk Induces COX-2 in Myofibroblasts via PKC/PKD
-
批准号:8078851
-
项目类别:
-
资助金额:$15.14万
-
财政年份:2010
-
负责人:James Yoo
-
依托单位:
国内基金
海外基金
登录
查看更多内容
RIPK3蛋白及其RHIM结构域在脓毒症早期炎症反应和脏器损伤中的作用和机制研究
-
批准号:82372167
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:江继宏
-
依托单位:
肠道菌群介导的脱氧胆酸激活S1PR2/NLRP3/IL-1β通路在炎症性肠病合并艰难梭菌感染中的致病机制研究
-
批准号:82372306
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:彭奕冰
-
依托单位:
YTHDF1通过m6A修饰调控耳蜗毛细胞炎症反应在老年性聋中的作用机制研究
-
批准号:82371140
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:李姝娜
-
依托单位:
多孔Ti-MSNs@MGF+DX抗炎—成肌体系应用于颞下颌关节假体的作用和机制研究
-
批准号:82370984
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:郑吉驷
-
依托单位:
上皮祖细胞应答巨噬细胞分泌因子IL-1β参与炎症微环境下输卵管纤毛分化障碍的机制研究
-
批准号:82371691
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:张健
-
依托单位:
基于仿生矿化法构建氢离子捕获的炎症调节性水凝胶微球在卒中治疗中的研究
-
批准号:82372120
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:阮慧瞳
-
依托单位:
Caspase8和RIP3调控细胞程序性坏死的关键机制研究
-
批准号:31970688
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:章海兵
-
依托单位:
炎症因子调控干眼病眼表黏蛋白表达的分子机制
-
批准号:81100636
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:王艳
-
依托单位:
TRAM基因选择性调控LPS失控性炎症反应的实验研究
-
批准号:81071588
-
项目类别:面上项目
-
资助金额:33.0万元
-
批准年份:2010
-
负责人:陈力勇
-
依托单位: